Imbio Segmentation Editing Tool software— 510(k) K180129
Substantially EquivalentImbio, LLC
FDA 510(k) clearance K180129 for Imbio Segmentation Editing Tool software, Substantially Equivalent on 2018-03-16. Applicant: Imbio, LLC.
Clearance details
- Applicant
- Imbio, LLC
- Product code
- Code LLZ
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Minneapolis, MN, US
Adverse events under product code LLZ
product code LLZ- Death
- 13
- Total
- 13
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.